Your Shopping Cart Is Empty
| Report Code: A01980 | Jun 2017 | Pages: 150 | ||
| Tables: 62 | Charts: 34 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Precision Medicine Market
Request Now !The precision medicine market was valued at $3,516 million in 2016, and is estimated to reach at $7,746 million by 2023, registering a CAGR of 11.9% from 2017 to 2023. Precision medicine is based on a unique concept that states, two people infected with same disease dont need to have same physical response toward the disease. However, it depends on the surrounding environment and influence of genes and symptoms of patient. Moreover, it also depends on patients ability of responding to that particular disease, which enables the doctors and researchers to organize the required treatment. Precision medicine commonly includes use of system biology and panomics to determine the reason for an individual patient's illness at the molecular level. Followed by the use of concentrated medications to address individual patient's illness. Precision medicine offers many advantages such as efficient treatment customized to patients needs and category of disease. Moreover, precision medicine can reduce cost of treatment and help decrease repeated administration of medications.
The precision medicine market is segmented based on technology, sequencing technology, product, application and geography. Based on technology, it is divided into genomics, transcriptomics and epigenomics. Based on sequencing technology, the market is bifurcated into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, chain termination sequencing and nanopore sequencing. Based on product, the precision medicine market is subdivided into consumables, instruments and services. Based on applications it is classified into oncology, CNS, immunology, respiratory medicine, infections, and other applications. Based on end users, it is categorized into diagnostic tool companies, pharma & biotech companies, clinical laboratories, and healthcare IT/big data Companies. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Global Precision Medicine Market Segmentation
The precision medicine market is expected to grow at a productive rate during the forecast period. Surge in global incidence of cancer and increase in ageing population susceptible to disease are expected to boost the demand of precision medicines. Government initiative & grants and private companies investing in R&D of precision medicines is expected to boost the market growth.
Global Precision Medicine Market, By Geography, 2016 (%)
The report provides extensive competitive analysis and profiles of key market players, such as, Roche Holding AG, Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN, Quest Diagnostics, Laboratory Corporation of America Holdings, Novartis AG, AstraZeneca, Bristol-Myers Squibb, and Eli Lilly & Company.
The other players in the value chain include Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, and Pfizer Inc.
Key Benefits
Precision Medicine Market Report Highlights
| Aspects | Details |
|---|---|
| By TECHNOLOGY |
|
| By SEQUENICNG TECHNOLOGY |
|
| By PRODUCT |
|
| By APPLICATION |
|
| By END USERS |
|
| By GEOGRAPHY |
|
| Key Market Players | ELI LILLY & COMPANY (ELC), ILLUMINA, INC, THERMO FISHER SCIENTIFIC, INC, NOVARTIS AG (NAG), LABORATORY CORPORATION OF AMERICA HOLDINGS (LCAH), BRISTOL-MYERS SQUIBB (BMS), ASTRAZENECA, QIAGEN N.V.,, QUEST DIAGNOSTICS (QD), ROCHE HOLDING AG (ROCHE) |
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING
3.4. PATENTS ANALYSIS
3.4.1. Patent analysis by year
3.4.2. Patent analysis by region
3.5. PORTER’S FIVE FORCES ANALYSIS
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities
CHAPTER 4 GLOBAL PRECISION MEDICINE MARKET, BY TECHNOLOGY
4.1. OVERVIEW
4.1.1. Market size & forecast
4.2. GENOMICS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.3. TRANSCRIPTOMICS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast
4.4. EPIGENOMICS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast
CHAPTER 5 GLOBAL PRECISION MEDICINE MARKET, BY SEQUENICNG TECHNOLOGY
5.1. OVERVIEW
5.1.1. Market size & forecast
5.2. SEQEUNCING BY SYNTHESIS (SBS)
5.2.1. Market size & forecast
5.3. ION SEMICONDUCTOR SEQUENCING (ISS)
5.3.1. Market size & forecast
5.4. SEQEUNCING BY LIGATION (SBL)
5.4.1. Market size & forecast
5.5. PYROSEQUENCING
5.5.1. Market size & forecast
5.6. SINGLE MOLECULE REAL TIME SEQUENCING (SMRT)
5.6.1. Market size & forecast
5.7. NANOPORE SEQUENCING
5.7.1. Market size & forecast
CHAPTER 6 GLOBAL PRECISION MEDICINE MARKET, BY PRODUCT
6.1. OVERVIEW
6.1.1. Market size & forecast
6.2. CONSUMABLES
6.2.1. Key market trends
6.2.2. Growth factors and opportunities
6.2.3. Market size & forecast
6.3. INSTRUMENTS
6.3.1. Key market trends
6.3.2. Growth factors and opportunities
6.3.3. Market size & forecast
6.4. SERVICES
6.4.1. Key market trends
6.4.2. Growth factors and opportunities
6.4.3. Market size & forecast
CHAPTER 7 GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION
7.1. OVERVIEW
7.1.1. Market size & forecast
7.2. ONCOLOGY
7.2.1. Market size & forecast
7.3. CENTRAL NERVOUS SYSTEM (CNS)
7.3.1. Market size & forecast
7.4. IMMUNOLOGY
7.4.1. Market size & forecast
7.5. RESPIRATORY MEDICINE
7.5.1. Market size & forecast
7.6. INFECTION
7.6.1. Market size & forecast
7.7. OTHER APPLICATION
7.7.1. Market size & forecast
CHAPTER 8 GLOBAL PRECISION MEDICINE MARKET, BY END USERS
8.1. OVERVIEW
8.1.1. Market size & forecast
8.2. PHARMA & BIOTECH COMPANIES
8.2.1. Market size & forecast
8.3. DIAGNOSTIC TOOL COMPANIES
8.3.1. Market size & forecast
8.4. HEALTHCARE IT/ BIG DATA COMPANIES
8.4.1. Market size & forecast
8.5. CLINICAL LABORATORIES
8.5.1. Market size & forecast
CHAPTER 9 GLOBAL PRECISION MEDICINE MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.2. NORTH AMERICA
9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size & forecast
9.2.3.1. U.S. market size and forecast
9.2.3.2. Canada market size and forecast
9.2.3.3. Mexico market size and forecast
9.3. EUROPE
9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size & forecast
9.3.3.1. Germany market size and forecast
9.3.3.2. France market size and forecast
9.3.3.3. UK market size and forecast
9.3.3.4. Italy market size and forecast
9.3.3.5. Spain market size and forecast
9.3.3.6. Rest of Europe market size and forecast
9.4. ASIA-PACIFIC
9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Market size & forecast
9.4.3.1. Japan market size and forecast
9.4.3.2. China market size and forecast
9.4.3.3. Australia market size and forecast
9.4.3.4. India market size and forecast
9.4.3.5. South Korea market size and forecast
9.4.3.6. Taiwan market size and forecast
9.4.3.7. Rest of Asia-Pacific market size and forecast
9.5. LAMEA
9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size & forecast
9.5.3.1. Brazil market size and forecast
9.5.3.2. Turkey market size and forecast
9.5.3.3. Saudi Arabia market size and forecast
9.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 10 COMPANY PROFILES
10.1. ILLUMINA, INC
10.1.1. Operating business segments
10.1.2. Business performance
10.1.3. Key strategic moves and developments
10.2. THERMO FISHER SCIENTIFIC, INC
10.2.1. Operating business segments
10.2.2. Business performance
10.2.3. Key strategic moves and developments
10.3. ROCHE HOLDING AG (ROCHE)
10.3.1. Operating business segments
10.3.2. Business performance
10.3.3. Key strategic moves and developments
10.4. LABORATORY CORPORATION OF AMERICA HOLDINGS (LCAH)
10.4.1. Operating business segments
10.4.2. Business performance
10.4.3. Key strategic moves and developments
10.5. QUEST DIAGNOSTICS (QD)
10.5.1. Operating business segments
10.5.2. Business performance
10.5.3. Key strategic moves and developments
10.6. QIAGEN N.V.,
10.6.1. Operating business segments
10.6.2. Business performance
10.6.3. Key strategic moves and developments
10.7. ASTRAZENECA
10.7.1. Operating business segments
10.7.2. Business performance
10.7.3. Key strategic moves and developments
10.8. NOVARTIS AG (NAG)
10.8.1. Operating business segments
10.8.2. Business performance
10.8.3. Key strategic moves and developments
10.9. BRISTOL-MYERS SQUIBB (BMS)
10.9.1. Operating business segments
10.9.2. Business performance
10.9.3. Key strategic moves and developments
10.10. ELI LILLY & COMPANY (ELC)
10.10.1. Operating business segments
10.10.2. Business performance
10.10.3. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL PRECISION MEDICINE MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 2. GENOMICS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. TRANSCRIPTOMICS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. EPIGENOMICS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL PRECISION MEDICINE MARKET, BY SEQUENCING TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 6. SBS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. ISS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 8. SBL PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. PYROSEQUENCING PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. SMRT PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. NANOPORE SEQUENCING PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL PRECISION MEDICINE MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 13. CONSUMABLES PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. INSTRUMENTS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. SERVICES PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17. ONCOLOGY PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. CNS PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. IMMUNOLOGY PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. RESPIRATORY MEDICINE PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 21. INFECTION PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. OTHER APPLICATION PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. GLOBAL PRECISION MEDICINE MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 24. PHARMA & BIOTECH COMPANIES PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 25. PHARMACEUTICAL COMPANY PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. HEALTHCARE IT/ BIG DATA COMPANIES PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 27. CLINICAL LABORATORIES PRECISION MEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA PRECISION MEDICINE MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA PRECISION MEDICINE MARKET, BY SEQUENCING TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA PRECISION MEDICINE MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA PRECISION MEDICINE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 35. EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 36. EUROPE PRECISION MEDICINE MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 37. EUROPE PRECISION MEDICINE MARKET, BY SEQUENCING TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 38. EUROPE PRECISION MEDICINE MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 39. EUROPE PRECISION MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 40. EUROPE PRECISION MEDICINE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 42. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 43. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY SEQUENCING TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC PRECISION MEDICINE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 47. LAMEA PRECISION MEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 48. LAMEA PRECISION MEDICINE MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 49. LAMEA PRECISION MEDICINE MARKET, BY SEQUENCING TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 50. LAMEA PRECISION MEDICINE MARKET, BY PRODUCT 2016-2023 ($MILLION)
TABLE 51. LAMEA PRECISION MEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 52. LAMEA PRECISION MEDICINE MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 53. ILLUMINA, INC: COMPANY SNAPSHOT
TABLE 54. THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
TABLE 55. ROCHE: COMPANY SNAPSHOT
TABLE 56. LCAH: COMPANY SNAPSHOT
TABLE 57. QD: COMPANY SNAPSHOT
TABLE 58. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 59. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 60. NAG: COMPANY SNAPSHOT
TABLE 61. BMS: COMPANY SNAPSHOT
TABLE 62. ELC: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 1. PRECISION MEDICINE MARKET: MARKET SEGMENATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 5. TOP PLAYER POSITIONING: GLOBAL PRECISION MEDICINE MARKET
FIGURE 6. PATENT ANALYSIS BY REGION
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. PRECISION MEDICINE MARKET: TECHNOLOGY SEGMENATION
FIGURE 13. PRECISION MEDICINE MARKET:Â SEQUENCING TECHNOLOGY SEGMENATION
FIGURE 14. PRECISION MEDICINE MARKET: PRODUCT SEGMENATION
FIGURE 15. U.S. PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 16. CANADA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 17. MEXICO PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 18. GERMANY PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 19. FRANCE PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 20. UK PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 21. ITALY PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 22. SPAIN PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 23. REST OF EUROPE PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 24. JAPAN PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 25. CHINA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 26. AUSTRALIA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 27. INDIA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 28. SOUTH KOREA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 29. TAIWAN PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 30. REST OF ASIA-PACIFIC PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 31. BRAZIL PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 32. TURKEY PRECISION MEDICINE MARKET, 2016-20223 ($MILLION)
FIGURE 33. SAUDI ARABIA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 34. REST OF LAMEA PRECISION MEDICINE MARKET, 2016-2023 ($MILLION)
Precision medicine is an innovative approach toward personalization of healthcare; wherein, doctors and researchers plan treatment considering patients socioeconomic status, lifestyle, and differences in genes. Structuring personalized treatment supports doctors to attend issue at its source. This procedure also has different advantages, which include reduced number of drug administrations and low treatment cost. With technological advancements in genomics and genetic research, precision medicine has developed over time for efficient treatment of sophisticated diseases. Enhanced progression of precision medicine can be attributed to the growth and integration of cognitive computing and data analytics with healthcare.
Upsurge in demand for quality healthcare and medications & surge in global incidences of cancer boost the market growth. In addition, recent development in technology and government initiatives exemplified by precision medicine cohort program initiate by National Institute of health with $130 million from Project management institute (PMI). Furthermore, National Cancer Institute (U.S.) is working on a cancer genomics project linked to the use of precision medicine. Surge in investment of private Biotech and pharma companies concerning R&D in precision medicine is expected to fuel the market.
Precision medicines are used prominently for the treatment of cancer, however these days, they are also preferred to treat patients suffering from diabetes, neurology and cardiology related diseases, rare illnesses, and conditions or disorders linked to aging. Precision medicine aids researchers to develop drugs related to treatment of cancer based on unique genomic setting of patients. Drugs such as Herceptin, Tarceva, and Gleevec work efficiently with certain unique genetic profile of patients.
With special assistance from U.S. government (Precision Medicine Initiative announced by American president Barack Obama), the precision medicine market is expected to witness remarkable growth in North America. Presence of renowned, well-equipped, private, and government research facilities and pharmaceutical companies augment the development of the precision medicine market. Increase in government grants and initiatives to modernize healthcare infrastructure assist the growth of the market in Asia-Pacific.
Start reading instantly.
This Report and over 66,965+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report